TY - JOUR
T1 - Ovarian tissue cryopreservation in breast cancer patients
T2 - glass half empty or glass half full?
AU - Andersen, Claus Y
AU - Donnez, Jacques
AU - Ernst, Erik
AU - Gook, Debbie
AU - Pellicer, Antonio
AU - Von Wolff, Michael
AU - Suzuki, Nao
AU - Roux, Christophe
AU - Dolmans, Marie-Madeleine
N1 - Copyright © 2024 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
PY - 2025/1
Y1 - 2025/1
N2 - This is a commentary to a paper recently published in RBMOnline by Macklon and De Vos, in which they argue for a discontinuation of ovarian tissue freezing for fertility preservation in women with breast cancer. Instead, they suggest the use of oocyte vitrification following ovarian stimulation as the preferred method of fertility preservation. This commentary presents nine separate arguments that should be considered in the context of ovarian tissue freezing and fertility preservation in girls and women. Collectively, the authors support ovarian tissue freezing going forward and suggest continuing this procedure for fertility preservation in women with breast cancer. Ovarian tissue freezing represents several advantages for patients and provides them with more options following treatment compared with oocyte vitrification.
AB - This is a commentary to a paper recently published in RBMOnline by Macklon and De Vos, in which they argue for a discontinuation of ovarian tissue freezing for fertility preservation in women with breast cancer. Instead, they suggest the use of oocyte vitrification following ovarian stimulation as the preferred method of fertility preservation. This commentary presents nine separate arguments that should be considered in the context of ovarian tissue freezing and fertility preservation in girls and women. Collectively, the authors support ovarian tissue freezing going forward and suggest continuing this procedure for fertility preservation in women with breast cancer. Ovarian tissue freezing represents several advantages for patients and provides them with more options following treatment compared with oocyte vitrification.
UR - http://www.scopus.com/inward/record.url?scp=85209072362&partnerID=8YFLogxK
U2 - 10.1016/j.rbmo.2024.104442
DO - 10.1016/j.rbmo.2024.104442
M3 - Comment/debate
C2 - 39561658
SN - 1472-6483
VL - 50
SP - 104442
JO - Reproductive BioMedicine Online
JF - Reproductive BioMedicine Online
IS - 1
M1 - 104442
ER -